N

NovaBay Pharmaceuticals
D

NBY

0.70270
USD
0.02
(3.19%)
مغلق
حجم التداول
785
الربح لكل سهم
-7
العائد الربحي
-
P/E
-0
حجم السوق
3,433,176
أصول ذات صلة
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    A
    ATOS
    -0.09000
    (-6.57%)
    1.28000 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    I
    IBIO
    0.14700
    (6.84%)
    2.29700 USD
    I
    INO
    -0.54000
    (-11.25%)
    4.26000 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    O
    OCUL
    -0.77000
    (-7.75%)
    9.16000 USD
    S
    SELB
    -0.07020
    (-7.39%)
    0.88010 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    المزيد
الأخبار

العنوان: NovaBay Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratorytested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.